申报总数
公司
▲ 买入(0 笔)
▼ 卖出(0 笔)
最新申报发布于 2026年10月18日(Botanix Pharmaceuticals Ltd)。
内部人交易记录
已披露买入
0
已披露卖出
0
信号历史
无可用的信号评分。
Daniel Sharp Date of last notice 24 April 2026 Date that director ceased to be director 17 October 2026 Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust:交易记录概览
一笔交易,一个日期:2026年10月18日,Daniel Sharp Date of last notice 24 April 2026 Date that director ceased to be director 17 October 2026 Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust申报了在Botanix Pharmaceuticals Ltd的一笔交易。目前尚无更长的历史。数据来源:高管申报(ASX)。过往交易不代表未来收益。
与 Daniel Sharp Date of last notice 24 April 2026 Date that director ceased to be director 17 October 2026 Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust 相关的公司和市场
打开公司页面,查看内部人交易、基本面数据以及分析师一致预期(如有)。
申报1 总计
- 股票ASXASX:2924-03149761-6A1349834
1 条申报中的 1 条